This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The FDA has authorized Vitestro's Aletta system, the first standalone robotic device for ...

“Blood draws are one of the most commonly performed medical procedures in the United States, yet patients may face delays due to a growing shortage of trained phlebotomists,” Michelle Tarver, Director ...

Nikkei 225 Complete Strategy】 You can check all Nikkei stocks from here. (Save to My Page/♡ Recommended)*This article is ...

Harrison County, OH — Long before electric motors transformed farm work, farmers relied on steam and gas-powered machines to run their equipment — loud, fume-filled technology that many people today ...

Dear Mayo Clinic: I’ve heard about advances being made in diagnosing a number of cancers. Prostate cancer runs in my family. What’s changing in detecting and treating this cancer? Answer: The most ...

Blood collection is among the most common procedures performed in healthcare, with applications across primary care, hospital clinics, emergency departments, inpatient units, surgery, oncology, ...

Create an account to access more content and features on IEEE Spectrum, including the ability to save articles to read later, download Spectrum Collections, and participate in conversations with ...

The Aletta from startup Vitestro uses near-infrared light and ultrasound to find veins, then executes the blood collection process from tourniquet application to bandaging.

One minute and 49 seconds, that was the median time a machine needed to read a patient’s arm, choose a vein, insert a needle, fill the tubes, and withdraw, across the Dutch clinical trial that carried ...

On Wednesday, the U.S. Food and Drug Administration authorized the first robotic blood-draw device, addressing the shortage of phlebotomists throughout the nation. The Aletta is the first standalone ...

Sudden unexpected infant deaths now drive over a third of the Black-white infant mortality gap, a JAMA study shows. Safe sleep steps inside. Novo Nordisk Licenses Experimental Once-Weekly Obesity Pill ...